SignalsMonitor LIVE INTELLIGENCE
CONFLICTQUIET

25 days ago

Stopping Ozempic may raise heart attack and stroke risk

SIGNALSMONITORHEALTH

What's happening

SignalsMonitor is following this as a conflict story. ScienceDaily Health and ScienceDaily Top News are the outlets attached to this story. The first report grouped here was at 21 Sept 2026, 13:35 UTC. 2 material updates are listed in the timeline. The headline in use is “Stopping Ozempic may raise heart attack and stroke risk”. This note is SignalsMonitor's own briefing, not the publisher's article.

What we know

A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them.

ScienceDaily HealthRead at ScienceDaily Health

Story timeline

Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.

  1. First reported by ScienceDaily Top News

    Stopping Ozempic may raise heart attack and stroke risk

Same story, different outlets

2 headlines

Each line is that outlet's headline. The article stays on the publisher's site.